Rapid Communication: Key Changes to the Treatment of Drug-resistant Tuberculosis

Providing evidence-based guidelines to inform public health service delivery for Member States and other stakeholders is one of the core responsibilities of the World Health Organization (WHO). To support countries in responding to the challenges of TB and drug-resistant TB, the WHO Global TB Programme regularly issues evidence-based guidelines using the international GRADE4 (Grading of Recommendations, Assessment, Development and Evaluation) approach for scientific evidence assessment.